Predicting Medicine Shortages: The Power of Global Data

In the complex world of healthcare logistics, timing is everything. A delay of weeks, or even days, in identifying a medicine shortage can mean the difference between seamless patient care and a frantic scramble for alternatives. Traditionally, the UK’s approach to medicine supply issues has often been reactive, waiting for official domestic notifications before taking action.

However, the supply chain doesn’t stop at the border. To truly build resilience and protect patient access to essential medicines, we must look further afield. By leveraging global supply chain data, we can spot the ripples of disruption in international markets long before they turn into waves on our own shores.

The Reactive Trap

Currently, many healthcare providers rely heavily on official UK-specific alerts, such as those from the Department of Health and Social Care (DHSC) or the Medicines and Healthcare products Regulatory Agency (MHRA). While these alerts are vital, they often arrive when the shortage is already acute.

This reactive model leaves little room for maneuver.

Pharmacists and procurement teams are forced into “fire-fighting” mode, sourcing alternative suppliers, managing patient expectations, and navigating price spikes, often when stock levels are already critical.

The solution lies in shifting from reactive management to proactive intelligence. By monitoring global data points, we can identify early warning signs and gain precious lead time to prepare.

Case Study 1: Quetiapine 50mg MR Tablets

The recent shortage of Quetiapine 50mg MR Tablets provides a textbook example of how global intelligence can offer a significant head start.

In the UK, the first official Supply Alert issued by the DHSC and NHS England arrived on 4 February 2025. However, the data trail leading up to this point was visible internationally months in advance.

The Timeline of Warning Signs:

  • Early December 2024: Fragmented and staggered shortage notifications started to emerge across Europe, with each report differing in timing, product specificity, and coding standards. Initial alerts from government bodies in Austria, Sweden, and Germany referenced disruptions to both branded and generic versions

  • December 2024: In parallel, Canadian authorities released generalized warnings covering multiple generic packs, but these were categorized using a different set of data schemas and lacked direct mapping to European datasets

  • Late January 2025: Ireland reported shortages, and the first UK-specific signal appeared on the MedSourcing Hub as a reported supply issue.

  • 4 February 2025: Official UK Supply Alert issued.

The Insight:
Had UK stakeholders been monitoring this global activity, they would have seen a clear pattern emerging two months before the official domestic alert. This 60-day window is invaluable. It allows teams to secure stock, review prescribing guidelines, or identify suitable alternatives before the rest of the market reacts. Furthermore, pricing data over the last 12 months showed a clear positive correlation between increasing prices and the number of reported issues, adding another layer of predictability to the event.

Case Study 2: Estradiol 50 Micrograms/24 Hour Patches

The supply issues surrounding Estradiol patches demonstrate that this isn’t an isolated incident but a recurring pattern. The data reveals a two-year timeframe of escalating alerts that culminated in a UK shortage.

The Timeline of Warning Signs:

  • December 2023: Early user-reported alerts appeared on the MedSourcing Hub.

  • January 2024: Sweden’s government body issued a shortage notification.

  • March 2024: A discontinuation surfaced in Australia, referencing distributor-level interruptions

  • July 2024: Denmark’s alert, triggered by increased demand.

  • December 2024: Northern Ireland reported shortages, Serious Shortage Protocols (SSPs) were issued, and the DHSC/NHS England released an official Supply Alert.

The Insight:
In this case, the indicators were flashing internationally nearly a full year before the critical UK alert in late 2024. The discontinuation in Australia and demand spikes in Denmark were clear indicators of a strained global supply chain. Tracking these international “weak signals” transforms them into actionable intelligence.

The Role of MedSupply Intelligence

We cut through the noise, untangle the data chaos, and empower you with the clarity and confidence you need in uncertain times. We understand how daunting it is to face a blizzard of unclear alerts and incompatible codes when patient care is on the line. Our solution doesn’t just deliver notifications, it brings order to the fragmentation, translating scattered global signals into actionable insights you can trust.

Let’s put the power of predictive insight in your hands. If you’re ready to see how global data can work for you, reach out for a personalised walkthrough. We’re passionate about building resilience together and giving you the confidence to act before the next crisis hits. Talk to us about your challenges and see what we can unlock for you.

Key Benefits of a Global View:

  1. Early Risk Detection: Identifying shortages in neighboring or supplying countries (like Germany or Ireland) provides a reliable proxy for future UK availability.

  2. Market Resilience: Understanding that a “local” shortage is often a global manufacturing issue prevents wasted effort trying to source from equally affected regions.

  3. Cost Mitigation: Early awareness allows for better budget planning before panic buying drives prices up.

Conclusion

The evidence is clear: relying solely on domestic reporting mechanisms is no longer sufficient for a modern, resilient healthcare system. The supply chains for Quetiapine and Estradiol are global, and our monitoring systems must match that scope.

By embracing data that looks beyond our borders, healthcare providers can reclaim control. We can transition from managing crises to managing risks, ensuring that when the waves of disruption hit, our defenses are already in place.

Ready to get ahead of the next shortage? Explore how global data insights can transform your procurement strategy.